Tender/ Acquisition/ Takeover/ Purchase Offer::Mandatory

Issuer & Securities

Issuer/ Manager
TIANJIN ZHONG XIN PHARM GROUP
Security
TIANJIN ZHONG XIN PHARM GROUP - CNE100000924 - T14

Announcement Details

Announcement Title
Mandatory Tender/ Acquisition/ Takeover/ Purchase Offer
Date &Time of Broadcast
19-Jan-2021 19:01:19
Status
New
Corporate Action Reference
SG210119TENDZQKM
Submitted By (Co./ Ind. Name)
Jiao Yan
Designation
Secretary to the Board

Event Narrative

Narrative Type
Narrative Text
OfferorTianjin Pharmaceutical (Singapore) International Investment Pte. Ltd.
Additional TextPlease refer to the attached Offeree Response Announcement.

The attached Offeree Response Announcement is the same announcement as released by the Company on 20 December 2020, and the reason for the re-upload using the Tender/ Acquisition/ Takeover/ Purchase Offer::Mandatory template is pursuant to CDP s request.

Disbursement Details

Existing Security Details
Disbursement Type
Cash
Cash Payment Details
Offer Price
USD 0.893

Attachments

Related Announcements